Prevalence and clinical outcome of mitral-valve prolapse
- PMID: 10387935
- DOI: 10.1056/NEJM199907013410101
Prevalence and clinical outcome of mitral-valve prolapse
Abstract
Background: Mitral-valve prolapse has been described as a common disease with frequent complications. To determine the prevalence of mitral-valve prolapse in the general population, as diagnosed with the use of current two-dimensional echocardiographic criteria, we examined the echocardiograms of 1845 women and 1646 men (mean [+/-SD] age, 54.7+/-10.0 years) who participated in the fifth examination of the offspring cohort of the Framingham Heart Study.
Methods: Classic mitral-valve prolapse was defined as superior displacement of the mitral leaflets of more than 2 mm during systole and as a maximal leaflet thickness of at least 5 mm during diastasis, and nonclassic prolapse was defined as displacement of more than 2 mm, with a maximal thickness of less than 5 mm.
Results: A total of 84 subjects (2.4 percent) had mitral-valve prolapse: 47 (1.3 percent) had classic prolapse, and 37 (1.1 percent) had nonclassic prolapse. Their age and sex distributions were similar to those of the subjects without prolapse. None of the subjects with prolapse had a history of heart failure, one (1.2 percent) had atrial fibrillation, one (1.2 percent) had cerebrovascular disease, and three (3.6 percent) had syncope, as compared with unadjusted prevalences of these findings in the subjects without prolapse of 0.7, 1.7, 1.5, and 3.0 percent, respectively. The frequencies of chest pain, dyspnea, and electrocardiographic abnormalities were similar among subjects with prolapse and those without prolapse. The subjects with prolapse were leaner (P<0.001) and had a greater degree of mitral regurgitation than those without prolapse, but on average the regurgitation was classified as trace or mild.
Conclusions: In a community based sample of the population, the prevalence of mitral-valve prolapse was lower than previously reported. The prevalence of adverse sequelae commonly associated with mitral-valve prolapse in studies of patients referred for that diagnosis was also low.
Comment in
-
Perspectives on mitral-valve prolapse.N Engl J Med. 1999 Jul 1;341(1):48-50. doi: 10.1056/NEJM199907013410109. N Engl J Med. 1999. PMID: 10387961 No abstract available.
-
Mitral-valve prolapse.N Engl J Med. 1999 Nov 4;341(19):1471; author reply 1472. doi: 10.1056/NEJM199911043411912. N Engl J Med. 1999. PMID: 10577098 No abstract available.
-
Mitral-valve prolapse.N Engl J Med. 1999 Nov 4;341(19):1471-2. N Engl J Med. 1999. PMID: 10577099 No abstract available.
Similar articles
-
Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse.N Engl J Med. 1989 Apr 20;320(16):1031-6. doi: 10.1056/NEJM198904203201602. N Engl J Med. 1989. PMID: 2927482
-
Transesophageal echocardiographic assessment of the contribution of intrinsic tissue thickness to the appearance of a thick mitral valve in patients with mitral valve prolapse.J Am Coll Cardiol. 1996 Aug;28(2):465-71. doi: 10.1016/0735-1097(96)00160-X. J Am Coll Cardiol. 1996. PMID: 8800127
-
Lack of evidence of an association between mitral-valve prolapse and stroke in young patients.N Engl J Med. 1999 Jul 1;341(1):8-13. doi: 10.1056/NEJM199907013410102. N Engl J Med. 1999. PMID: 10387936
-
Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality.J Am Coll Cardiol. 1988 May;11(5):1010-9. doi: 10.1016/s0735-1097(98)90059-6. J Am Coll Cardiol. 1988. PMID: 3281989 Review.
-
The pathology of mitral valve prolapse.Herz. 1988 Aug;13(4):215-26. Herz. 1988. PMID: 3049284 Review.
Cited by
-
TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.Cardiovasc Res. 2013 Jul 1;99(1):175-84. doi: 10.1093/cvr/cvt083. Epub 2013 Apr 3. Cardiovasc Res. 2013. PMID: 23554457 Free PMC article.
-
Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome.PLoS One. 2012;7(9):e44639. doi: 10.1371/journal.pone.0044639. Epub 2012 Sep 11. PLoS One. 2012. PMID: 22984535 Free PMC article.
-
A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels.Animals (Basel). 2020 Oct 16;10(10):1895. doi: 10.3390/ani10101895. Animals (Basel). 2020. PMID: 33081147 Free PMC article.
-
Prognostic value of forward flow indices in primary mitral regurgitation due to mitral valve prolapse.Front Cardiovasc Med. 2023 Feb 23;10:1076708. doi: 10.3389/fcvm.2023.1076708. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36910534 Free PMC article.
-
Three-dimensional echocardiography and mitral valve disease.Curr Cardiol Rep. 2010 May;12(3):243-9. doi: 10.1007/s11886-010-0103-z. Curr Cardiol Rep. 2010. PMID: 20424968 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical